As of July 30, 2015, evolocumab (Repatha) has not been approved by FDA, but there are plenty of references to work with in the clicinal trials and the FDA Briefing Document:
* https://clinicaltrials.gov/ct2/results?term=evolocumab&Search=Search
* http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM450072.pdf

For the peripheral network, we will try sampling from the following search term:
* ldl cholesterol reduction (9722 hits spanning 1971-2015)
